Doxorubicin Olefin Impurity - Request Quote
Doxorubicin Olefin Impurity
| SZ CAT No: | SZ-D051012 |
| CAS No | NA |
| Mol.F. | C26H25NO10 |
| Mol.Wt. | 511.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Doxorubicin Olefin Impurity is chemically 4-(((2S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-3,4,6,11-tetrahydrotetracene-2-carboxylic acid. Doxorubicin Olefin Impurity is supplied with detailed characterization data compliant with regulatory guideline. Doxorubicin Olefin Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxorubicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Doxorubicin Olefin Impurity
Purchase Doxorubicin Olefin Impurity
Doxorubicin Olefin Impurity suppliers
Doxorubicin Olefin Impurity manufacturers
Doxorubicin Olefin Impurity price
Order Doxorubicin Olefin Impurity
Enquire Doxorubicin Olefin Impurity
Doxorubicin Olefin Impurity cost
Doxorubicin Olefin Impurity Supplier
Doxorubicin Olefin Impurity Distributor
Doxorubicin Olefin Impurity for Method Validation
Doxorubicin Reference Standard
Doxorubicin Olefin Impurity for ANDA Filing
Doxorubicin Olefin Impurity for Forced Degradation Studies
Doxorubicin Olefin Impurity Identification Standards
Doxorubicin Olefin Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.